这是一项多中心的观察性研究,旨在评估从COVID-19中康复的患者重新开始抗瘤治疗的安全性
Liting Guo1, Chenfei Zhou1, Wenqi Xi1
1Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Future oncology (London, England)
|December 3, 2025
概括
在COVID-19恢复后重新开始癌症治疗通常对固体瘤患者来说是安全的. 建议在治疗期间监测全身炎症和凝血功能,以管理潜在的风险.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 临床医学 临床医学
背景情况:
- 癌症患者的COVID-19风险增加.
- 在COVID-19后恢复抗瘤治疗的安全性尚不确定.
研究的目的:
- 评估癌症患者在COVID-19康复后重新开始抗瘤治疗的安全性.
- 评估治疗出现的不良事件 (TEAE) 和实验室参数变化.
主要方法:
- 未来的,多中心研究 (2023年1月至3月).
- 查了419名癌症患者从COVID-19中康复.
- 在COVID-19后3个月内恢复的第一轮治疗中评估的TEAE.
主要成果:
- 包括270名患者;常见等级≥3个TEAE:疲劳 (3.3%),贫血 (1.1%).
- 没有严重的心脏毒性或胸部CT异常.
- 治疗后观察到增加的D-二聚合物,心脏 I 和炎症性细胞因子.
结论:
- 在COVID-19恢复后重新开始全身抗瘤治疗通常对固体瘤患者来说是安全的.
- 在治疗期间,监测全身炎症和凝血是至关重要的.
更多相关视频
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
12.4K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Bioavailability Study Design: Healthy Subjects Versus Patients
135
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
135
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
